Skip to main content
. 2016 Mar 27;7(18):26070–26086. doi: 10.18632/oncotarget.8429

Figure 2. Differentially expressed miRNAs in lung cancer plasma samples compared to those in control plasma samples determined by TLDA.

Figure 2

Lung cancer plasma samples (red); control plasma samples (blue). (Assay centric).